Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Oumédaly Reman"'
Autor:
Cindy Castrale, Wael El Haggan, Françoise Chapon, Oumedaly Reman, Thierry Lobbedez, Jean Philippe Ryckelynck, Bruno Hurault de Ligny
Publikováno v:
Journal of Transplantation, Vol 2011 (2011)
Lymphomatoid granulomatosis (LYG) in renal transplant recipients is rare multisystemic angiocentric lymphoproliferative disorder with significant malignant potential. Here, we describe LYG in a 70-year-old renal allograft recipient who, 4 years after
Externí odkaz:
https://doaj.org/article/fb01f3c5e6b34bc0bce1af981f80d8ed
Publikováno v:
Case Reports in Medicine, Vol 2009 (2009)
Graft versus tumor effect has been described in solid metastatic tumor. We reported here the case of a patient treated for an acute myeloid leukemia with reduced-intensity conditioned allograft and the effect of this procedure on concomitant of renal
Externí odkaz:
https://doaj.org/article/fbf223b6828d49e2ae6adbf57ad01282
Autor:
Mohamad Mohty, Florent Malard, Didier Blaise, Noel Milpied, Gérard Socié, Anne Huynh, Oumédaly Reman, Ibrahim Yakoub-Agha, Sabine Furst, Thierry Guillaume, Resa Tabrizi, Stéphane Vigouroux, Pierre Peterlin, Jean El-Cheikh, Philippe Moreau, Myriam Labopin, Patrice Chevallier
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
The prognosis of patients with acute myeloid leukemia in whom primary treatment fails remains very poor. In order to improve such patients’ outcome, we conducted a phase 2, prospective, multicenter trial to test the feasibility of a new sequential
Externí odkaz:
https://doaj.org/article/bfaa27940471457e8ca88a34fe2b66d6
Autor:
Eric Van Den Neste, Olivier Casasnovas, Marc André, Mohamed Touati, Delphine Senecal, Véronique Edeline, Aspasia Stamatoullas, Luc Fornecker, Bénédicte Deau, Thomas Gastinne, Oumédaly Reman, Isabelle Gaillard, Cécile Borel, Pauline Brice, Christophe Fermé
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
The Hodgkin’s Lymphoma Committee of the Lymphoma Study Association (LYSA) gathered in 2012 to prepare guidelines on the management of transplant-eligible patients with relapsing or refractory Hodgkin’s lymphoma. The working group is made up of a
Externí odkaz:
https://doaj.org/article/e040960e05534e6c9bd9eeaf36a0dc45
Autor:
Christophe, Fermé, José, Thomas, Pauline, Brice, Olivier, Casasnovas, Andrej, Vranovsky, Serge, Bologna, Pieternella J, Lugtenburg, Réda, Bouabdallah, Patrice, Carde, Catherine, Sebban, Houchingue, Eghbali, Gilles, Salles, Gustaaf W, van Imhoff, Antoine, Thyss, Evert M, Noordijk, Oumédaly, Reman, Marnix L M, Lybeert, Maud, Janvier, Michele, Spina, Bruno, Audhuy, John M M, Raemaekers, Richard, Delarue, Bruno, Anglaret, Okke, de Weerdt, Zora, Marjanovic, Robbert J H A, Tersteeg, Daphne, de Jong, Josette, Brière, Michel, Henry-Amar
Publikováno v:
European journal of cancer (Oxford, England : 1990). 81
For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down. The H9-U trial compared three modalities of chemotherapy followed by involved-field radiotherapy (IFRT) in patients wi
Publikováno v:
Bulletin du Cancer. 100:317-321
We describe three cases of intravascular lymphoma B with different clinical presentation: one case of a cutaneous variant and two cases with surrenal and cutaneous localisation. All patients are in complete remission after chemotherapy alone or after
Publikováno v:
Bulletin du cancer. 100(4)
We describe three cases of intravascular lymphoma B with different clinical presentation: one case of a cutaneous variant and two cases with surrenal and cutaneous localisation. All patients are in complete remission after chemotherapy alone or after
Autor:
Blandine, Beaupain, Thierry, Leblanc, Oumédaly, Reman, Olivier, Hermine, Jean-Pierre, Vannier, Felipe, Suarez, Patrick, Lutz, Pierre, Bordigoni, Anne, Jourdain, Michele, Schoenvald, Marie, Ouachee, Sylvie, François, Fréderic, Kohser, Fabrice, Jardin, Gilles, Devouassoux, Yves, Bertrand, Raphaele, Nove-Josserand, Jean, Donadieu
Publikováno v:
Pediatric bloodcancer. 53(6)
To examine the efficacy and safety of pegfilgrastim in patients with congenital neutropenia (CN).Seventeen patients enrolled in the French Severe CN Register received pegfilgrastim.Median age at pegfilgrastim introduction was 19.1 years (range 3.9-52
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charles, Dumontet, Nicolas, Mounier, Jean Nicolas, Munck, André, Bosly, Frank, Morschauser, Daniele, Simon, Gérald, Marit, Olivier, Casasnovas, Oumédaly, Reman, Thierry, Molina, Felix, Reyes, Bertrand, Coiffier
Publikováno v:
British journal of haematology. 118(1)
Death during the induction phase of chemotherapy remains a common event in patients with aggressive non-Hodgkin's lymphoma (NHL). In a series of patients with aggressive NHL homogeneously treated with intensive induction chemotherapy [ACVB (doxorubic